Empagliflozin in Renal Transplant Recipients

Inclusion Criteria

• •Renal transplant recipient transplanted more than 1 year ago
• •Stable renal function (\<20% deviation in serum creatinine within last 2 months)
• •Stable immunosuppressive therapy ≥3 months before inclusion
• •Diagnosed with PTDM:
• •(fasting plasma glucose ≥7.0 mmol/l and/or 2-hour plasma glucose ≥11.1 mmol/l following an oral glucose tolerance test)
• •Signed informed consent and expected cooperation of the patients